Human papillomavirus screening: Difference between revisions
(Category) |
m (Bot: Removing from Primary care) |
||
| Line 53: | Line 53: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Revision as of 22:14, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
|
Human papillomavirus Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Human papillomavirus screening On the Web |
|
American Roentgen Ray Society Images of Human papillomavirus screening |
|
Risk calculators and risk factors for Human papillomavirus screening |
Overview
High-risk HPV types are associated with 70% of cervical cancers in females having persistent infection.[1] Due to this strong association between HPV and cervical cancer, cervical cancer screening is recommended in all females from age 21. According to the US Preventive Services Task Force (USPSTF), specific screening guidelines for cervical cancer includes screening all females from age 21 to 65 for cervical cancer.[2][3]
Screening
High-risk HPV types are associated with 70% of cervical cancers in females having persistent infection.[1] Due to this strong association between HPV and cervical cancer, cervical cancer screening is recommended in all females from age 21. According to the US Preventive Services Task Force (USPSTF), specific screening guidelines for cervical cancer is described below:[2][3]
| Population | Recommendations |
|---|---|
| Women 21 to 65 (pap Smear) |
|
| Women aged 30-65 |
|
| Women younger than 21 |
|
| Women older than 65 (who have had adequate prior screening) |
|
| Women after hysterectomy with removal of cervix (no h/o high grade precancer or cervical cancer) |
|
| Women before age 30 |
|
References
- ↑ 1.0 1.1 http://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#epi Accessed on October 13, 2016
- ↑ 2.0 2.1 Moyer VA, U.S. Preventive Services Task Force (2012). "Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement". Ann Intern Med. 156 (12): 880–91, W312. doi:10.7326/0003-4819-156-12-201206190-00424. PMID 22711081.
- ↑ 3.0 3.1 McGraw SL, Ferrante JM (2014). "Update on prevention and screening of cervical cancer". World J Clin Oncol. 5 (4): 744–52. doi:10.5306/wjco.v5.i4.744. PMC 4129537. PMID 25302174.
- ↑ Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T; et al. (2008). "Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005". Ann Intern Med. 148 (7): 493–500. PMID 18378945 PMID: 18378945 Check
|pmid=value (help).